Western Pennsylvania Hospital Cancer Institute — Pittsburgh, Pennsylvania

Western Pennsylvania Hospital Cancer Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15224.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Western Pennsylvania Hospital Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Myelodysplastic Syndrome, Iron Overload.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Western Pennsylvania Hospital Cancer Institute?

Western Pennsylvania Hospital Cancer Institute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Western Pennsylvania Hospital Cancer Institute conducted?

Western Pennsylvania Hospital Cancer Institute has 1 clinical trials on record. Their work covers Myelodysplastic Syndrome, Iron Overload.

Is Western Pennsylvania Hospital Cancer Institute accredited by Crixeo Health?

Western Pennsylvania Hospital Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Western Pennsylvania Hospital Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.